These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 15538750

  • 1. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
    Koch A, Weber N, Waha A, Hartmann W, Denkhaus D, Behrens J, Birchmeier W, von Schweinitz D, Pietsch T.
    J Pathol; 2004 Dec; 204(5):546-54. PubMed ID: 15538750
    [Abstract] [Full Text] [Related]

  • 2. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.
    Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T.
    Cancer Res; 1999 Jan 15; 59(2):269-73. PubMed ID: 9927029
    [Abstract] [Full Text] [Related]

  • 3. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
    Koch A, Hrychyk A, Hartmann W, Waha A, Mikeska T, Waha A, Schüller U, Sörensen N, Berthold F, Goodyer CG, Wiestler OD, Birchmeier W, Behrens J, Pietsch T.
    Int J Cancer; 2007 Jul 15; 121(2):284-91. PubMed ID: 17373666
    [Abstract] [Full Text] [Related]

  • 4. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W.
    Oncogene; 2002 Jul 18; 21(31):4863-71. PubMed ID: 12101426
    [Abstract] [Full Text] [Related]

  • 5. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A, Waha A, Hartmann W, Hrychyk A, Schüller U, Waha A, Wharton KA, Fuchs SY, von Schweinitz D, Pietsch T.
    Clin Cancer Res; 2005 Jun 15; 11(12):4295-304. PubMed ID: 15958610
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
    Miyoshi Y, Iwao K, Nawa G, Yoshikawa H, Ochi T, Nakamura Y.
    Oncol Res; 1998 Jun 15; 10(11-12):591-4. PubMed ID: 10367940
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
    Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sörensen N, Berthold F, Behrens J, Birchmeier W, Wiestler OD, Pietsch T.
    Cancer Res; 2001 Oct 01; 61(19):7039-43. PubMed ID: 11585731
    [Abstract] [Full Text] [Related]

  • 13. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
    Gad S, Teboul D, Lièvre A, Goasguen N, Berger A, Beaune P, Laurent-Puig P.
    BMC Cancer; 2004 Jul 09; 4():31. PubMed ID: 15245581
    [Abstract] [Full Text] [Related]

  • 14. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.
    Takayasu H, Horie H, Hiyama E, Matsunaga T, Hayashi Y, Watanabe Y, Suita S, Kaneko M, Sasaki F, Hashizume K, Ozaki T, Furuuchi K, Tada M, Ohnuma N, Nakagawara A.
    Clin Cancer Res; 2001 Apr 09; 7(4):901-8. PubMed ID: 11309340
    [Abstract] [Full Text] [Related]

  • 15. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam.
    Anna CH, Sills RC, Foley JF, Stockton PS, Ton TV, Devereux TR.
    Cancer Res; 2000 Jun 01; 60(11):2864-8. PubMed ID: 10850429
    [Abstract] [Full Text] [Related]

  • 16. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
    Chen YW, Jeng YM, Yeh SH, Chen PJ.
    Hepatology; 2002 Oct 01; 36(4 Pt 1):927-35. PubMed ID: 12297840
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patients.
    D'Orazio D, Muller PY, Heinimann K, Albrecht C, Bendik I, Herzog U, Tondelli P, Bauerfeind P, Müller H, Dobbie Z.
    Anticancer Res; 2002 Oct 01; 22(6A):3409-14. PubMed ID: 12530096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.